Sensing antibody functions with a novel CCR8-responsive engineered cell
Human chemokine receptor 8 (CCR8) is a promising drug target for immunotherapy of cancer and autoimmune diseases. Monoclonal antibody-based CCR8 targeted treatment shows significant inhibition in tumor growth. The inhibition of CCR8 results in the improvement of antitumor immunity and patient surviv...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2024-04-01
|
| Colecção: | Acta Biochimica Polonica |
| Assuntos: | |
| Acesso em linha: | https://www.frontierspartnerships.org/articles/10.3389/abp.2024.12185/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|